Market Experts' LIVE Stock Recommendations: Hold Garden Reach, Buy Aurobindo Pharma
Disclaimer: The views and opinions expressed by the investment advisers are of their own and not of NDTV Profit. NDTV Profit advises readers to consult their financial advisers before investment.
Stock Recommendation Live: IDBI Capital Suggests Buy For AB Capital
IDBI Capital suggested a buy for Aditya Birla Capital. The target price is Rs 273 apiece, and the stop loss is at Rs 245 apiece.
Stock Recommendation Live: Vedanta Approves Interim Dividend Of Rs 7 Per Share
Vedanta has approved its first interim dividend of Rs 7 per share for the fiscal year 2026. The company has also sanctioned the payment of Rs 2,737 crore in interim dividends.
Stock Recommendation Live: The Streets Suggest Buy For Indian Overseas Bank
The Streets Trading Strategist and Fund Manager Kunal Rambhia suggested a buy for Indian Overseas Bank Ltd. The target price is Rs 41. The stop loss is at Rs 36 apiece.
Stock Recommendation Live: Dalmia Bharat Gets Buy From Reliance Securities
Dalmia Bharat received a buy target from Reliance Securities. Its equity research head gave a target price of Rs 2,250 apiece. The stop loss is at Rs 1,930 apiece.
Stock Recommendation Live: Divi's Laboratories In Focus
Novartis and MSN have settled on 659 patent for Drug entresto
The legal fight now moves to the next patent.
Patent for entresto expires in Nov-26 and related exclusivity expires in May-27.
This can see upgrades in Divi's Labs FY26 and FY27 numbers.
Divis Lab supplies API for Entresto
Contributes 8% to Divis Lab Revenue
